We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.7B
AUM Growth
-$296M
Cap. Flow
+$44.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$22.3M
2
AMGN icon
Amgen
AMGN
+$21.9M
3
BABA icon
Alibaba
BABA
+$18.9M
4
SLB icon
SLB Ltd
SLB
+$18M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.76%
2 Technology 13.33%
3 Consumer Discretionary 12.45%
4 Industrials 11.02%
5 Financials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
1051
Repligen
RGEN
$6.91B
$293K 0.01%
+10,551
New +$381K
ISEE
1052
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$293K 0.01%
7,250
-17,085
-70% -$905K
SNOW
1053
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
$293K 0.01%
+33,841
New +$332K
BSAC icon
1054
Banco Santander Chile
BSAC
$16.1B
$292K 0.01%
16,063
+3,596
+29% +$70.2K
APEX
1055
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$292K 0.01%
628
+223
+55% +$165K
TAX
1056
DELISTED
Liberty Tax, Inc. Class A
TAX
$289K 0.01%
12,438
-1,270
-9% -$30.9K
PCTY icon
1057
Paylocity
PCTY
$7.75B
$287K 0.01%
9,586
-16,831
-64% -$572K
SPPI
1058
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$285K 0.01%
47,668
-6,560
-12% -$45.5K
BRO icon
1059
Brown & Brown
BRO
$25.1B
$283K 0.01%
18,296
-6,800
-27% -$112K
CBD
1060
DELISTED
Companhia Brasileira de Distribuicao
CBD
$283K 0.01%
22,594
-68,606
-75% -$1.28M
LPSN icon
1061
LivePerson
LPSN
$22M
$282K 0.01%
+2,492
New +$337K
BCE icon
1062
BCE
BCE
$20.8B
$280K 0.01%
6,854
-929
-12% -$38.1K
MGNX icon
1063
MacroGenics
MGNX
$233M
$279K 0.01%
+13,059
New +$410K
HTWR
1064
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$278K 0.01%
5,316
-16,874
-76% -$1.28M
UMC icon
1065
United Microelectronic
UMC
$42.9B
$276K 0.01%
170,458
ANF icon
1066
Abercrombie & Fitch
ANF
$4.55B
$275K 0.01%
12,984
-55,784
-81% -$1.13M
NP
1067
DELISTED
Neenah, Inc. Common Stock
NP
$274K 0.01%
+4,714
New +$276K
CUB
1068
DELISTED
Cubic Corporation
CUB
$274K 0.01%
+6,542
New +$283K
FCF icon
1069
First Commonwealth Financial
FCF
$2.22B
$273K 0.01%
+30,060
New +$275K
CYTK icon
1070
Cytokinetics
CYTK
$10.6B
$271K 0.01%
+40,551
New +$277K
RSE
1071
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
$270K 0.01%
+17,386
New +$291K
VIVO
1072
DELISTED
Meridian Bioscience Inc
VIVO
$269K 0.01%
15,778
+3,412
+28% +$62.4K
DBRG icon
1073
DigitalBridge
DBRG
$2.92B
$268K 0.01%
4,674
-17,462
-79% -$1.22M
HAYN
1074
DELISTED
Haynes International, Inc.
HAYN
$268K 0.01%
7,101
+2,701
+61% +$110K
NTK
1075
DELISTED
NORTEK INC COM NEW (DE)
NTK
$268K 0.01%
+4,238
New +$331K

Similar funds

A.R.T. Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
  • A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
  • A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
  • A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
  • A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.